Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Macrogenics
(NQ:
MGNX
)
3.105
+0.065 (+2.14%)
Streaming Delayed Price
Updated: 1:47 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Macrogenics
< Previous
1
2
3
4
5
6
7
8
Next >
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
November 07, 2023
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
MacroGenics (MGNX) Q3 2023 Earnings Call Transcript
November 07, 2023
MGNX earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Earnings Scheduled For November 6, 2023
November 06, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via
Benzinga
A Preview Of Macrogenics's Earnings
November 03, 2023
Via
Benzinga
3 Under-the-Radar Biotech Stocks to Buy in 2023
August 19, 2023
All three biotech companies focus on oncology therapies.
Via
The Motley Fool
Why Shares of MacroGenics Are Jumping Thursday
August 10, 2023
The company announced second-quarter earnings.
Via
The Motley Fool
MacroGenics (MGNX) Q1 2023 Earnings Call Transcript
May 10, 2023
MGNX earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Recap: Macrogenics Q1 Earnings
May 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
August 10, 2023
Via
Benzinga
Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
August 10, 2023
Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results.
Via
Benzinga
Earnings Outlook For Macrogenics
May 08, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About Macrogenics
March 21, 2023
Via
Benzinga
Why MacroGenics Stock Tumbled Today
March 17, 2023
The company had quite a comedown shortly after releasing its latest set of annual results.
Via
The Motley Fool
Disinflation Talk Grows, Rate Hike Bets Plummet: Top 5 ETFs Rallying On CPI Miss
August 10, 2023
The disinflationary trend continued in July, even though the annual CPI inflation rate saw a slight increase from 3% to 3.2% last month, breaking a streak of 12 consecutive months of decline.
Via
Benzinga
Topics
ETFs
Economy
Exposures
Interest Rates
Alibaba, Illumina, CyberArk Software And Other Big Stocks Moving Higher On Thursday
August 10, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 350 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
MacroGenics (MGNX) Q2 2023 Earnings Call Transcript
August 09, 2023
MGNX earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Macrogenics's Return On Capital Employed Insights
March 16, 2023
Via
Benzinga
MacroGenics (MGNX) Q4 2022 Earnings Call Transcript
March 15, 2023
MGNX earnings call for the period ending December 31, 2022.
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 05, 2023
Via
Benzinga
Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 10, 2023
Gainers PLx Pharma Inc. (NASDAQ: PLXP) gained 128.2% to $0.2399 after dropping over 13% on Thursday.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 03, 2023
Via
Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
March 23, 2023
Via
Benzinga
Why MacroGenics Stock Inched Higher on Monday
March 20, 2023
A pair of more-bullish analyst evaluations gave hope to investors.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
March 17, 2023
Via
Benzinga
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 16, 2023
Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy...
Via
Benzinga
Why Shares of MacroGenics Climbed Thursday
March 16, 2023
The cancer-focused biotech delivered a strong earnings report.
Via
The Motley Fool
Signet Jewelers, Designer Brands, Academy Sports and Outdoors And Other Big Stocks Moving Higher On Thursday
March 16, 2023
U.S. stocks traded lower, with the Dow Jones dropping more than 250 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Earnings Scheduled For March 15, 2023
March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.
Via
Benzinga
Illumina, Seagen And Other Big Stocks Moving Higher On Monday
March 13, 2023
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Shares of MacroGenics Jumped Thursday
March 09, 2023
The company made a sale worth as much as $200 million for the royalty rights for its type-1 diabetes therapy.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.